Amino acids induce indicators of response to injury in glomerular mesangial cells

American Journal of Physiology - Renal Physiology

Volumn 285, Issue 1 54-1, 2003, Pages

  Meek, Rick L ^a   Cooney, Sheryl K ^a   Flynn, Stephanie D ^a   Chouinard, Robert F ^a   Poczatek, Maria H ^b   Murphy Ullrich, Joanne E ^b   Tuttle, Katherine R ^a  

^a Heart Institute of Spokane   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Extracellular matrix proteins; Hyperglycemia; Mesangial cell proliferation; Thrombospondin 1; Transforming growth factor

Indexed keywords

AMINO ACID; ARGININE; BIOLOGICAL MARKER; COLLAGEN TYPE 4; FIBRONECTIN; GLUCOSE; MATRIX PROTEIN; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SCLEROPROTEIN; TGFB1 PROTEIN, RAT; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DAMAGE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULUS; HEMODYNAMICS; MESANGIUM CELL; METABOLITE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DIET; RAT; WESTERN BLOTTING; ANIMAL; CELL DIVISION; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; MESANGIUM; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

AMINO ACIDS; ANIMALS; ARGININE; CELL DIVISION; CELL SURVIVAL; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLOMERULAR MESANGIUM; GLUCOSE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0038383768     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00419.2002     Document Type: Article

References (48)

1. Anderson MM, Requena JR, Crowley JR, Thorpe SR, and Heinecke JW. The myeloperoxidase system of human phagocytes generates N-ε-(carboxymethyi)lysine on proteins. A mechanism for producing advanced glycation end products at sites of inflammation. J Clin Invest 104: 103-113, 1999.
2. 1 and matrix mRNAs in mesangial cells. Kidney Int 50: 745-753, 1996.
3. Aoki TT, Brennan MF, Muller WA, Soeldner SJ, Alpert JS, Saltz SB, Kaufmann RL, Tan HM, and Cahill GF. Amino acid levels across normal forearm muscle and splanchnic bed after a protein meal. Am J Clin Nutr 29: 340-350, 1976.
4. Becker BN, Yasuda T, Kondo S, Vaikunth S, Homma T, and Harris RC. Mechanical stretch/relaxation stimulates a cellular renin-angiotensin system in cultured rat mesangial cells. Exp Nephrol 6: 57-66, 1998.
5. Brenner BM, Meyer TW, and Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307: 652-659, 1982.
6. Bucala R, Tracey KJ, and Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87: 432-438, 1991.
7. 1 production and protein kinase C activity in glomerular endothelial cells. Kidney Int 59: 673-681, 2001.
8. Chouinard RF, Meek RL, Cooney SK, and Tuttle KR. Effects of amino acids and glucose on mesangial cell aminopeptidase A and angiotensin receptors. Kidney Int 61: S106-S109, 2002.
9. Craven PA, Studer RK, Felder J, Phillips S, and DeRubertis FR. Nitric oxide inhibition of transforming growth factor-β and collagen synthesis in mesangial cells. Diabetes 46: 671-681, 1997.
10. Felig P, Wahren J, Sherwin R, and Palaiologos G. Amino acid and protein metabolism in diabetes mellitus. Arch Intern Med 137: 507-513, 1977.
11. Gansevoort RT, de Zeeuw D, and de Jong PE. Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease. Nephrol Dial Transplant 10: 497-504, 1995.
12. Ha H and Lee HB. Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int 77: S19-S25, 2000.
13. Haneda M, Araki S, Togawa M, Sugimoto T, Isono M, and Kikkawa R. Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 46: 847-853, 1997.
14. Hansen HP, Tauber-Lassen E, Jensen BR, and Parving HH. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int 62: 220-228, 2002.
15. Hugo C, Pichler R, Meek R, Gordon K, Kyriakides T, Floege J, Bornstein P, Couser WG, and Johnson RJ. Thrombospondin 1 is expressed by proliferating mesangial cells and is up-regulated by PDGF and bFGF in vivo. Kidney Int 48: 1846-1856, 1995.
16. Ishii N, Patel KP, Lane PH, Taylor T, Bian K, Murad F, Pollock JS, and Carmines PK. Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J Am Soc Nephrol 12: 1630-1639, 2001.
17. 1 and matrix by high glucose in mesangial cells. J Am Soc Nephrol 11: 2222-2230, 2000.
18. Kagami S, Border WA, Miller DE, and Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93: 2431-2437, 1994.
19. Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F, and Brady HR. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 274: 5830-5834, 1999.
20. Murphy-Ullrich JE and Poczatek M. Activation of latent TGF-β by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev 11: 59-69, 2000.
21. Narita I, Border WA, Ketteler M, Ruoslahti E, and Noble NA. L-Arginine may mediate the therapeutic effects of low protein diets. Proc Natl Acad Sci USA 92: 4552-4556, 1995.
22. Nishikawa T, Edelstein D, and Brownlee M. The missing link: a single unifying mechanism for diabetic complications. Kidney Int 77: S26-S30, 2000.
23. O'Donnell MP, Kasiske BL, Schmitz PG, and Keane WF. High protein intake accelerates glomerulosclerosis independent of effects on glomerular hemodynamics. Kidney Int 37: 1263-1269, 1990.
24. Pedrini MT, Levey AS, Lau J, Chalmers TC, and Wang PH. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases. A meta-analysis. Ann Intern Med 124: 627-632, 1996.
25. 1 but not dexamethasone, down-regulates nitric oxide synthase mRNA after its induction by interleukin-1β in rat smooth muscle cells. J Biol Chem 269: 14595-14600, 1994.
26. Peters H, Border WA, and Noble NA. Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis. Kidney Int 57: 1493-1501, 2000.
27. phox in rat neutrophils. Clin Sci (Colch) 103: 403-408, 2002.
28. Poczatek MH, Hugo C, Darley-Usmar V, and Murphy-Ullrich JE. Glucose stimulation of transforming growth factor-β bioactivity in mesangial cells is mediated by thrombospondin-1. Am J Pathol 157: 1353-1363, 2000.
29. 1 receptors. Kidney Int 43: 177-184, 1994.
30. Ribeiro SM, Poczatek M, Schultz-Cherry S, Villain M, and Murphy-Ullrich JE. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-β. J Biol Chem 274:13586-13593, 1999.
31. Riser BL, Cortes P, Heilig C, Grondin J, Ladson-Wofford S, Patterson D, and Narins RG. Cyclic stretching force selectively up-regulates transforming growth factor-β isoforms in cultured rat mesangial cells. Am J Pathol 148: 1915-1923, 1996.
32. Ruilope LM, Casal MC, Praga M, Alcazar JM, Decap G, Lahera V, and Rodicio JL. Additive antiproteinuric effect of converting enzyme inhibition and a low protein intake. J Am Soc Nephrol 3: 1307-1311, 1992.
33. Schultz-Cherry S and Murphy-Ullrich JE. Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism. J Cell Biol 122: 923-932, 1993.
34. II in neonatal mesangial cells. Am J Physiol Renal Physiol 278: F676-F683, 2000.
35. Sellitti DF, Pithon-Curi TC, Hirszel P, and Doi SQ. Glutamine synergistically increases mesangial cell proliferation induced by high glucose levels (Abstract). J Am Soc Nephrol 13: 297A, 2002.
36. Sharma K and Ziyadeh FN. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-β as a key mediator. Diabetes 44: 1139-1146, 1995.
37. 1 and matrix proteins in chronic cyclosporine nephrotoxicity. Kidney Int 58: 1174-1185, 2000.
38. Singh R, Alavi N, Singh AK, and Leehey DJ. Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation. Diabetes 48: 2066-2073, 1999.
39. Tada H and Isogai S. The fibronectin production is increased by thrombospondin via activation of TGF-β in cultured human mesangial cells. Nephron 79: 38-43, 1998.
40. Trachtman H, Futterweit S, and Crimmins DL. High glucose inhibits nitric oxide production in cultured rat mesangial cells. J Am Soc Nephrol 8: 1276-1282, 1997.
41. Tuttle KR and Bruton JL. Effect of insulin therapy on renal hemodynamic response amino acids and renal hypertrophy in non-insulin-dependent diabetes. Kidney Int 43: 167-173, 1992.
42. Tuttle KR, Bruton JL, Perusek MC, Lancaster JL, Kopp DT, and DeFronzo RA. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus. N Engl J Med 324: 1626-1632, 1991.
43. Tuttle KR, Puhlman ME, Cooney SK, and Short RA. Effects of amino acids and glucagon on renal hemodynamics in type 1 diabetes. Am J Physiol Renal Physiol 282: F103-F112, 2002.
44. Wang S, Shiva S, Poczatek MH, Darley-Usmar V, and Murphy-Ullrich JE. Nitric oxide and cGMP-dependent protein kinase regulation of glucose-mediated thrombospondin 1-dependent transforming growth factor-β activation in mesangial cells. J Biol Chem 277: 9880-9888, 2002.
45. Wolf G. Cell cycle regulation in diabetic nephropathy. Kidney Int 77: S59-S66, 2000.
46. 1 in human mesangial cells exposed to high glucose. J Am Soc Nephrol 12: 703-712, 2001.
47. Zatz R, Meyer TW, Rennke HG, and Brenner BM. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 82: 5963-5967, 1985.
48. Ziyadeh FN, Sharma K, Ericksen M, and Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J Clin Invest 93: 536-542, 1994.